Tornling G, Unge G, Axelsson G, Noring L, Granerus A K
Eur J Respir Dis. 1986 Jan;68(1):35-8.
Pleural thickening was observed in 4 patients during treatment with bromocriptine in dosages of 10-90 mg/day. Three patients who received at least 50 mg/day developed respiratory symptoms, elevated ESR and pleural effusion, which were normalized after withdrawal of the drug or reduction of the dosage. However, the pleural thickening was not fully reversible in any of the patients.
在接受溴隐亭治疗（剂量为每日10 - 90毫克）的过程中，4名患者出现了胸膜增厚。3名每日接受至少50毫克溴隐亭治疗的患者出现了呼吸道症状、血沉加快和胸腔积液，在停药或减少剂量后这些症状恢复正常。然而，所有患者的胸膜增厚均未完全逆转。
